Clinical trials: sponsored by Case Comprehensive Cancer Center
HR-positive Breast Cancer
Vitamin B12 for Aromatase Inhibitors Associated Musculoskeletal Symptoms in Breast Cancer
Treatment of hormone receptor (HR)-positive breast cancer with Aromatase Inhibitors (AIs) can lead to associated musculoskeletal pain and may cause patients to discontinue important treatment.
- Trial name
- NCT04205786
- Testing
- Vitamin B12, Blood collection, Brief Pain Inventory - Short Form survey
- Where
- United States
- Sponsor
- Case Comprehensive Cancer Center
Myelodysplastic Syndrome (MDS)
CPX-351 Therapy for MDS After Hypomethylating Agent Failure
The purpose of this study is to evaluate the efficacy of treatment with CPX-351 (an FDA approved drug for the treatment of AML) in individuals with MDS while using a new stratification tool to predict outcomes of participants…
- Trial name
- NCT03957876
- Testing
- CPX-351
- Where
- United States
- Volunteers
- 4 people
- Sponsor
- Case Comprehensive Cancer Center
Pancreas Cancer, Pancreas Adenocarcinoma
CAPEcitabine eXtension of Adjuvant Therapy for Pancreatic Adenocarcinoma: (CAPE-X)
This study is being done to find out if extending adjuvant chemotherapy for patients by giving additional chemotherapy can lengthen the amount of time before their cancer comes back.
- Trial name
- NCT06110598
- Testing
- Capecitabine
- Where
- United States
- Sponsor
- Case Comprehensive Cancer Center
Stage III Melanoma, Stage IV Cutaneous Melanoma
Leveraging ctDNA Analysis to Improve Early Detection of Cancer Recurrence in the High-Risk Melanoma Setting
To generate meaningful data regarding ctDNA that would infer risk of recurrence in stage III melanoma patients.
- Trial name
- NCT05079113
- Where
- United States
- Volunteers
- 73 people
- Sponsor
- Case Comprehensive Cancer Center
Recurrent Squamous Cell Carcinoma of the Head and Neck, Metastatic Squamous Cell Carcinoma
ASTX727 and Nivolumab in Squamous Cell Carcinoma of the Head and Neck
The goal of this clinical trial is to see if the combination of experimental drug ASTX727 and Nivolumab enhances the antitumor immune response in participants will recurrent or metastatic squamous cell carcinoma of the head and…
- Conditions
- Recurrent Squamous Cell Carcinoma of the Head and Neck, Metastatic Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma
- Trial name
- NCT06357858
- Testing
- INQOVI (decitabine and cedazuridine), Nivolumab
- Where
- United States
- Sponsor
- Case Comprehensive Cancer Center
Breast Reconstruction
The Impact of Functional Medicine On Wound Healing From Delayed Autologous Breast Reconstruction
This study will examine if a functional medicine approach, delivered as an adjunct to standard of care, is feasible, safe, clinically beneficial and cost-effective for patients undergoing autologous breast reconstruction.
- Trial name
- NCT05028101
- Testing
- Delayed autologous breast reconstruction, Perioperative Functional Medicine (FM) Care
- Where
- United States
- Volunteers
- 7 people
- Sponsor
- Case Comprehensive Cancer Center
Breast Cancer
Role of Magnetic Resonance Fingerprinting and Quantitative MR Imaging in Breast Cancer
The purpose of this study is to determine if new methods of MRI imaging can better measure participants' response to chemotherapy treatment.
- Trial name
- NCT03650803
- Testing
- 3D MR Fingerprinting scan
- Where
- United States
- Volunteers
- 14 people
- Sponsor
- Case Comprehensive Cancer Center
Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma
Carfilzomib, Rituximab, and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Lymphoma
This phase I/II trial studies the side effects and best dose of carfilzomib when given together with rituximab and combination chemotherapy and to see how well they work in treating patients with diffuse large B-cell lymphoma.
- Conditions
- Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma
- Trial name
- NCT02073097
- Testing
- Carfilzomib, Rituximab, Cyclophosphamide
- Where
- 3 sites in United States
- Volunteers
- 48 people
- Sponsor
- Case Comprehensive Cancer Center
Rectal Neoplasms
Safety and Feasibility of PD-1 Blockade in the Treatment of dMMR or MSI-H Rectal Cancer
Colorectal cancer is the third most common cancer worldwide and the second leading cause of cancer mortality in the United States.
- Trial name
- NCT04357587
- Testing
- Pembrolizumab, External beam radiation, Capecitabine
- Where
- United States
- Volunteers
- 6 people
- Sponsor
- Case Comprehensive Cancer Center
Spinal Tumor
Optimal Timing of Postoperative Magnetic Resonance Imaging (MRI) in Patients With Extradural Spinal
This research study is evaluating suitability of a delayed magnetic resonance imaging (MRI) in management of spine tumors. Currently the standard of care is obtaining an MRI scan in the early postoperative period (within 72 hours…
- Trial name
- NCT02790294
- Testing
- Magnetic Resonance Imaging
- Where
- United States
- Volunteers
- 8 people
- Sponsor
- Case Comprehensive Cancer Center
Adenocarcinoma of the Prostate, Recurrent Prostate Cancer
Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate Cancer
This pilot clinical trial studies magnetic resonance (MRI)-guided focal stereotactic radiosurgery (SRS) in treating patients with low- or intermediate-risk localized prostate cancer.
- Conditions
- Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer
- Trial name
- NCT02163317
- Testing
- stereotactic radiosurgery, magnetic resonance imaging, quality-of-life assessment
- Where
- United States
- Volunteers
- 12 people
- Sponsor
- Case Comprehensive Cancer Center
Stage IV Non-Small Cell Lung Cancer
Pembrolizumab Alone or Sequentially Following Single Fraction Non-ablative Radiation to One of the Target Lesions, in Previously Treated Patients With Stage IV NSCLC
The goal of this clinical trial is to determine if low single palliative dose radiation to the lung cancer will improve your immune response against the tumor and if sequential treatment with pembrolizumab (the study drug) would…
- Trial name
- NCT02658097
- Testing
- Pembrolizumab, Single Fraction Radiation Therapy
- Where
- United States
- Volunteers
- 13 people
- Sponsor
- Case Comprehensive Cancer Center
Sickle Cell Disease, Sickle Cell Anemia
Hematopoietic Stem Cell Transplant for Sickle Cell Disease
This is a study of patients with sickle cell disease. It aims to find out if people with sickle cell disease can be cured by changing their immune system before they have blood stem cell transplants.
- Conditions
- Sickle Cell Disease, Sickle Cell Anemia, SCD
- Trial name
- NCT02065596
- Testing
- Fludarabine, Hematopoietic Stem Cell Transplant (HSCT)
- Where
- United States
- Volunteers
- 4 people
- Sponsor
- Case Comprehensive Cancer Center
Autologous Transplant, Myeloma
Mycobiome Supporting Diet to Reduce GI Toxicity Associated With ASCT
The purpose of this study is to determine if this specific Mycobiome Supporting Diet (MSD diet) can help reduce gut inflammation during post-transplant period.
- Trial name
- NCT04685525
- Testing
- Mycobiome Supporting Diet
- Where
- United States
- Sponsor
- Case Comprehensive Cancer Center
Colorectal Cancer, Rectal Cancer
Circulating Tumor DNA to Monitor the Efficacy of Total Neoadjuvant Therapy for Rectal Cancer
The purpose of this study is to use the SignateraTm assay created from rectal tumor biopsies to monitor participants' blood for fragments of DNA shed by tumor cells.
- Trial name
- NCT05356585
- Testing
- SignateraTM assay
- Where
- United States
- Sponsor
- Case Comprehensive Cancer Center
Metastatic Renal Cell Carcinoma
Intermittent Therapy in Metastatic Renal Cell Carcinoma Patients Treated With Ipilimumab and Nivolumab
This study is being done with patients with advanced kidney cancer (also called renal cell carcinoma or RCC). This is a research study involving the use of the drug Nivolumab (also known as Opdivo®).
- Trial name
- NCT03126331
- Testing
- Nivolumab, Ipilimumab
- Where
- United States
- Volunteers
- 26 people
- Sponsor
- Case Comprehensive Cancer Center
NSCLC, Non-small Cell Lung Cancer
Osimertinib With Stereotactic Radiosurgery (SRS) in Brain Metastases From EGFR Positive NSCLC
Investigating potential of controlling brain metastases in patients with EGFR positive NSCLC.
- Trial name
- NCT03535363
- Testing
- Osimertinib
- Where
- 2 sites in United States
- Volunteers
- 6 people
- Sponsor
- Case Comprehensive Cancer Center
Smoking Behaviors
C-FLASH (Cigarillo Flavor and Abuse Liability, Attention, and Substitution in youtH)
The purpose of this research is to understand how flavor affects young adult's perceptions of little cigar or cigarillo use.
- Trial name
- NCT04358705
- Testing
- Aim 1: Online survey, Eye Tracking Activity, Eye tracking survey
- Where
- United States
- Volunteers
- 658 people
- Sponsor
- Case Comprehensive Cancer Center
Adolescent and Young Adult Cancers
CyberCycling to Reduce Therapeutic Side Effects and Improve Quality of Life in AYA Cancers
Only a few clinical trials evaluating the potential benefits of exercise have been conducted in adolescents and young adults (AYA) with cancer and, no prior studies have evaluated the potential effects of 'cybercycling'…
- Trial name
- NCT02916472
- Testing
- CyberCycling, Stretching, Resistance Bands
- Where
- United States
- Volunteers
- 9 people
- Sponsor
- Case Comprehensive Cancer Center
Non-Small Cell Lung Cancer
Proton Based Cardiac Sparing Accelerated Fractionated RadioTherapy in Unresectable NSCLC
The purpose of this study is to treat participants with the combination of durvalumab (the study drug) and proton beam therapy. Proton beam therapy is a type of radiotherapy (RT) with a unique characteristic where the proton…
- Trial name
- NCT03818776
- Testing
- Durvalumab, Proton beam therapy RT
- Where
- United States
- Volunteers
- 7 people
- Sponsor
- Case Comprehensive Cancer Center